COMMUNIQUÉS West-GlobeNewswire

Rexahn Pharmaceuticals Announces Collaboration with Zhejiang Haichang Biotechnology Co., Ltd. for the Development of RX-0201 (Archexin®) for the treatment of Hepatocellular Carcinoma
08/02/2018
Haichang to fund development through completion of Phase IIa Proof-of-Concept Clinical Trial Clinical trials will be designed to meet both the US and China FDA requirements ROCKVILLE, Md., Feb. 08, 2018 (GLOBE NEWSWIRE [...]
Radius Health to Present at Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
WALTHAM, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative [...]
Emerald Health Therapeutics Announces $18 Million Prospectus Sale; Concurrent Secondary Sale
08/02/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) ("Emerald" [...]
HempAmericana Teams Up With High Times Magazine as CBD Oil Production Nears
08/02/2018
NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--HempAmericana, Inc. (OTC:HMPQ) is thrilled to announce that they are teaming up with the iconic cannabis media platform for coming coverage in the legendary [...]
Actinium Appoints Anil Kapur as Chief Commercial Officer to Build Critical Commercial & Launch Capabilities Focused on Myeloablation
08/02/2018
- Mr. Kapur joins Actinium with more than two decades of biopharmaceutical commercial experience at Johnson & Johnson, BAXALTA and Bristol-Myers Squibb - Global leader with deep expertise in Oncology Marketing [...]
Adverum Biotechnologies Announces Pricing of $60 Million Public Offering of Common Stock
08/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Nextech Keeps Focus on Care at the American Academy of Dermatology Annual Meeting
08/02/2018
TAMPA, Fla., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, showcases NexCloud, its exclusively dermatology-engineered cloud [...]
Capital Senior Living Corporation Announces Release Date for Fourth Quarter and Full Year 2017 Financial Results
08/02/2018
DALLAS, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE: CSU ) will host a conference call with senior management to discuss the Company’s fourth quarter and full year 2017 financial results. [...]
Arch Biopartners Arranges Convertible Note Financing
08/02/2018
TORONTO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture:ARCH) (OTCBB: ACHFF ), announced it has arranged a non-brokered, unsecured convertible note (“Note”) financing for [...]
Wave Life Sciences to Participate in Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE ), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined [...]
Innovation Pharmaceuticals Concludes Successful Phase 2a Trial of Kevetrin for Ovarian Cancer; Intra-Tumor Modulation of p53 Observed
08/02/2018
BEVERLY, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces the closure of its Phase 2a clinical trial ( [...]
Kura Oncology to Present at the Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
SAN DIEGO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]
Navamedic ASA: Invitation to presentation of fourth quarter 2017
08/02/2018
Navamedic ASA invites you to a presentation of the fourth quarter 2017 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Thursday 15 February. The presentation will start at 08.00 [...]
Anavex Life Sciences to Present at the 2018 BIO CEO & Investor Conference
08/02/2018
NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Millennium Blockchain Signs Letter-of-Intent to Invest $5 Million Into Healthcare Blockchain Company BurstIQ at #DAVOS2018
08/02/2018
Blockchain division negotiates first placement in Healthcare data blockchain use-case sector LAS VEGAS, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Millennium Blockchain Inc. (OTC:MBLC) (“Millennium Blockchain” or the “Company [...]
Resverlogix Highlights Key Accomplishments and 2018 Targets
08/02/2018
CALGARY, Alberta, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) highlighted today recent key accomplishments and 2018 targets. Recent Accomplishments The Company has [...]
Neuralstem to Participate at The Young Jewish Professionals CEO Healthcare Symposium
08/02/2018
GERMANTOWN, Md., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Richard Daly, Chairman and [...]
Proteostasis Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]
Edge Therapeutics to Present at Upcoming Investor Conferences in February
08/02/2018
BERKELEY HEIGHTS, N.J., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE ), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life- [...]

Pages